Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0bc184c2faabe538e3eae63b902e3ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ec16d37f046e8f22def1c9c7b050879 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-475 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
filingDate |
2003-07-17^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0f5fb2c24dfe1693daf11cb87a8527a |
publicationDate |
2004-01-22^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004006830-A2 |
titleOfInvention |
Use of ccn protein family members for the treatment of disorder associated to an altered calcium and/or sodium flux |
abstract |
The invention relates to the use of a CCN protein for the preparation of a drug for the treatment of a disorder associated to an altered calcium and/or sodium flux, and the pharmaceutical composition thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104749371-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103327027-A |
priorityDate |
2002-07-17^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |